Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
about
Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy.Progression of urothelial carcinoma in situ of the urinary bladder: a switch from luminal to basal phenotype and related therapeutic implications.Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.Bladder cancer.
P2860
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Summary and Recommendations fr ...... Muscle Invasive Bladder Cancer
@en
Summary and Recommendations fr ...... uscle Invasive Bladder Cancer.
@nl
type
label
Summary and Recommendations fr ...... Muscle Invasive Bladder Cancer
@en
Summary and Recommendations fr ...... uscle Invasive Bladder Cancer.
@nl
prefLabel
Summary and Recommendations fr ...... Muscle Invasive Bladder Cancer
@en
Summary and Recommendations fr ...... uscle Invasive Bladder Cancer.
@nl
P2093
P2860
P356
P1154
2-s2.0-85013165415
P1476
Summary and Recommendations fr ...... Muscle Invasive Bladder Cancer
@en
P2093
Abdul Tawab Amiri
Andrea B Apolo
Andrew Sharabi
Arlene H Sharpe
Ashish Kamat
Bhupinder Mann
Catherine M Tangen
Charles Drake
Colin P Dinney
David Kwiatkowski
P2860
P304
P356
10.3233/BLC-160053
P5530
P577
2016-04-27T00:00:00Z
P6179
1032474343